US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

2.350
+0.280+13.53%

Close Oct 14 16:00 ET

2.389
+0.039+1.67%

Post 20:02 ET

60.01MMarket Cap-1793P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-60.62%55.18K

22.61%55.18K

-15.08%140.11K

Operating revenue

--0

-58.40%55.18K

--0

47.00%55.18K

-0.96%132.64K

--0

Cost of revenue

Gross profit

Operating expense

5.84%8.18M

-17.17%4.38M

24.51%22.31M

-3.38%4.41M

2.82%4.89M

46.66%7.73M

58.54%5.28M

28.06%17.92M

40.26%4.56M

1.88%4.75M

Selling and administrative expenses

0.05%3.75M

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

-General and administrative expense

0.05%3.75M

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

Research and development costs

11.28%4.44M

-10.19%2.51M

37.52%11.52M

4.40%2.37M

20.50%2.37M

54.44%3.99M

79.33%2.79M

16.93%8.38M

54.42%2.27M

-20.67%1.96M

Operating profit

-5.84%-8.18M

16.29%-4.38M

-25.18%-22.25M

3.38%-4.41M

-2.82%-4.89M

-49.35%-7.73M

-59.03%-5.23M

-28.58%-17.78M

-42.15%-4.56M

-2.48%-4.75M

Net non-operating interest income expense

-34.94%84.53K

-24.16%115.3K

31.67%494.23K

-35.11%106.27K

-30.87%106K

116.91%129.93K

9,308.66%152.04K

2,904.06%375.36K

61,239.70%163.78K

3,017.77%153.33K

Non-operating interest income

----

31.67%494.23K

----

--375.36K

----

Total other finance cost

34.94%-84.53K

24.16%-115.3K

----

30.87%-106K

---129.93K

-9,308.66%-152.04K

----

-3,017.77%-153.33K

Other net income (expense)

27.61%-43.58K

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

Gain on sale of security

27.61%-43.58K

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

Income before tax

-6.27%-8.14M

21.99%-3.99M

-26.81%-22.19M

-2.46%-4.71M

-3.13%-4.7M

-50.93%-7.66M

-56.55%-5.12M

-26.00%-17.5M

-42.38%-4.6M

2.24%-4.55M

Income tax

-95.45%1.21K

18.81%19.87K

-14.74%79.28K

-81.43%14.5K

430.04%21.46K

190.72%26.59K

897.50%16.73K

2,219.76%92.98K

1,047.42%78.11K

-20.84%4.05K

Net income

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

Net income continuous Operations

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

Minority interest income

Net income attributable to the parent company

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

Basic earnings per share

32.26%-0.42

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

Diluted earnings per share

32.26%-0.42

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	-60.62%55.18K	0	0	0	22.61%55.18K	-15.08%140.11K	0	0
Operating revenue	--0	--0	-58.40%55.18K	--0	--0	--0	47.00%55.18K	-0.96%132.64K	--0	--0
Cost of revenue
Gross profit
Operating expense	5.84%8.18M	-17.17%4.38M	24.51%22.31M	-3.38%4.41M	2.82%4.89M	46.66%7.73M	58.54%5.28M	28.06%17.92M	40.26%4.56M	1.88%4.75M
Selling and administrative expenses	0.05%3.75M	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M
-General and administrative expense	0.05%3.75M	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M
Research and development costs	11.28%4.44M	-10.19%2.51M	37.52%11.52M	4.40%2.37M	20.50%2.37M	54.44%3.99M	79.33%2.79M	16.93%8.38M	54.42%2.27M	-20.67%1.96M
Operating profit	-5.84%-8.18M	16.29%-4.38M	-25.18%-22.25M	3.38%-4.41M	-2.82%-4.89M	-49.35%-7.73M	-59.03%-5.23M	-28.58%-17.78M	-42.15%-4.56M	-2.48%-4.75M
Net non-operating interest income expense	-34.94%84.53K	-24.16%115.3K	31.67%494.23K	-35.11%106.27K	-30.87%106K	116.91%129.93K	9,308.66%152.04K	2,904.06%375.36K	61,239.70%163.78K	3,017.77%153.33K
Non-operating interest income	----	----	31.67%494.23K	----	----	----	----	--375.36K	----	----
Total other finance cost	34.94%-84.53K	24.16%-115.3K	----	----	30.87%-106K	---129.93K	-9,308.66%-152.04K	----	----	-3,017.77%-153.33K
Other net income (expense)	27.61%-43.58K	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K
Gain on sale of security	27.61%-43.58K	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K
Income before tax	-6.27%-8.14M	21.99%-3.99M	-26.81%-22.19M	-2.46%-4.71M	-3.13%-4.7M	-50.93%-7.66M	-56.55%-5.12M	-26.00%-17.5M	-42.38%-4.6M	2.24%-4.55M
Income tax	-95.45%1.21K	18.81%19.87K	-14.74%79.28K	-81.43%14.5K	430.04%21.46K	190.72%26.59K	897.50%16.73K	2,219.76%92.98K	1,047.42%78.11K	-20.84%4.05K
Net income	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M
Net income continuous Operations	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M
Minority interest income
Net income attributable to the parent company	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M
Basic earnings per share	32.26%-0.42	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38
Diluted earnings per share	32.26%-0.42	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data